Occudo Quantitative Strategies LP Oramed Pharmaceuticals Inc. Transaction History

Occudo Quantitative Strategies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.21 - $12.03 $8,625 - $16,709	-1,389 Reduced 6.34%	20,515 $246,000
Q3 2022 Nov 14, 2022	SELL	$4.6 - $9.91 $360,235 - $776,071	-78,312 Reduced 78.14%	21,904 $142,000
Q2 2022 Aug 15, 2022	BUY	$3.72 - $9.0 $171,056 - $413,847	45,983 Added 84.79%	100,216 $459,000
Q1 2022 May 16, 2022	BUY	$8.19 - $13.89 $67,231 - $114,023	8,209 Added 17.84%	54,233 $469,000
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $20,015 - $45,874	1,542 Added 3.47%	46,024 $657,000

Q3 2021 Nov 15, 2021	BUY	$12.13 - $23.82 $203,007 - $398,651	16,736 Added 60.32%	44,482 $978,000
Q2 2021 Aug 16, 2021	BUY	$8.34 - $14.59 $46,261 - $80,930	5,547 Added 24.99%	27,746 $371,000
Q1 2021 May 14, 2021	BUY	$4.22 - $11.33 $93,679 - $251,514	22,199 New	22,199 $226,000

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $97.1M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.